Taro Pharmaceutical Industries Ltd. (TARO)
Jun 24, 2024 - TAR was delisted (reason: acquired by Sun Pharma)
42.97
0.00 (0.00%)
Inactive · Last trade price
on Jun 21, 2024
TARO Employees
Taro Pharmaceutical Industries had 1,554 employees as of March 31, 2023. The number of employees increased by 99 or 6.80% compared to the previous year.
Employees
1,554
Change (1Y)
99
Growth (1Y)
6.80%
Revenue / Employee
$404,879
Profits / Employee
$34,663
Market Cap
1.62B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 1,554 | 99 | 6.80% |
Mar 31, 2022 | 1,455 | 38 | 2.68% |
Mar 31, 2021 | 1,417 | -47 | -3.21% |
Mar 31, 2020 | 1,464 | 0 | - |
Mar 31, 2019 | 1,464 | -26 | -1.74% |
Mar 31, 2018 | 1,490 | 77 | 5.45% |
Mar 31, 2017 | 1,413 | 6 | 0.43% |
Mar 31, 2016 | 1,407 | 68 | 5.08% |
Mar 31, 2015 | 1,339 | -3 | -0.22% |
Mar 31, 2014 | 1,342 | 48 | 3.71% |
Mar 31, 2013 | 1,294 | 21 | 1.65% |
Mar 31, 2012 | 1,273 | 75 | 6.26% |
Dec 31, 2011 | 1,198 | 49 | 4.26% |
Dec 31, 2010 | 1,149 | -49 | -4.09% |
Dec 31, 2009 | 1,198 | 68 | 6.02% |
Dec 31, 2008 | 1,130 | 0 | - |
Dec 31, 2007 | 0 | -1,149 | -100.00% |
Dec 31, 2006 | 1,149 | -177 | -13.35% |
Dec 31, 2005 | 1,326 | -21 | -1.56% |
Dec 31, 2004 | 1,347 | -99 | -6.85% |
Dec 31, 2003 | 1,446 | 298 | 25.96% |
Dec 31, 2002 | 1,148 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
TARO News
- 3 months ago - Investors Are Invited By The Schall Law Firm To Join A Securities Fraud Case Against Taro Pharmaceutical Industries Ltd. - Accesswire
- 3 months ago - Taro Pharmaceutical Industries Ltd Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation - Accesswire
- 6 months ago - Sun Pharma Completes Taro Merger - PRNewsWire
- 7 months ago - Taro Shareholders Approve Merger with Sun Pharma - PRNewsWire
- 7 months ago - Taro Provides Results for Year Ended March 31, 2024 - Business Wire
- 7 months ago - Taro to Release Full Year Results on May 20, 2024 - Business Wire
- 8 months ago - Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger - Business Wire
- 8 months ago - TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO - Business Wire